APA

Guo S., Booten S. L., Watt A., Alvarado L., Freier S. M., Teckman J. H., McCaleb M. L. & Monia B. P. (20140723). Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease. : Rare diseases (Austin, Tex.).

Chicago

Guo Shuling, Booten Sheri L, Watt Andrew, Alvarado Luis, Freier Susan M, Teckman Jeffery H, McCaleb Michael L and Monia Brett P. 20140723. Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease. : Rare diseases (Austin, Tex.).

Harvard

Guo S., Booten S. L., Watt A., Alvarado L., Freier S. M., Teckman J. H., McCaleb M. L. and Monia B. P. (20140723). Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease. : Rare diseases (Austin, Tex.).

MLA

Guo Shuling, Booten Sheri L, Watt Andrew, Alvarado Luis, Freier Susan M, Teckman Jeffery H, McCaleb Michael L and Monia Brett P. Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease. : Rare diseases (Austin, Tex.). 20140723.